Aptus Pharma Share Price
11 Aug, 2026 4:00 PM (IST)
Aptus Pharma Performance
- Today's Low
- ₹269
- Today's High
- ₹269
- 52 Week Low
- ₹32
- 52 Week High
- ₹310
- Open Price₹269
- Previous Close₹274
- Volume24,800
- 50 DMA₹239.90
- 100 DMA₹203.00
- 200 DMA-
Aptus Pharma Chart
Investment Returns
- Over 1 Month + 20%
- Over 3 Month + 58.12%
- Over 6 Month + 183.48%
Smart Investing Starts Here Start SIP with Aptus Pharma for Steady Growth!
Aptus Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 99.8
- PEG Ratio
- -
- Market Cap Cr
- 461
- P/B Ratio
- 19.7
- Average True Range
- 10.1
- EPS
- 2.7
- Dividend Yield
- 0
- MACD Signal
- 13.3
- RSI
- 56.12
- MFI
- 65.98
Latest Stock News Updates
Please find attached Clarification letter in respect of Outcome of Board meeting held on 08.08.2026 and submitted on 08.08.2026 for approval of Preferential issue of Shares
- BSE India
- 1 day 10 hours ago
please find attached outcome of board meeting dated 08.08.2026 for approval of preferential issue of shares
- BSE India
- 3 days 7 hours ago
Aptus Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2026 ,inter alia, to consider and approve Intimation of Board Meeting to be held on Saturday, August 8, 2026
- BSE India
- 6 days 6 hours ago
Aptus Pharma Financials
Aptus Pharma Technicals
EMA & SMA
- Bearish Moving Average 5
- Bullish Moving Average 9
- 20 Day
- ₹266.10
- 50 Day
- ₹239.90
- 100 Day
- ₹203.00
- 200 Day
- -
Resistance and Support
- R3 268.80
- R2 268.80
- R1 268.80
- S1 268.80
- S2 268.80
- S3 268.80
Aptus Pharma Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-08-08 | Preferential issue of shares | |
| 2026-06-12 | Preferential Issue of shares & Others | Inter-alia, to consider 1. Evaluate and deliberate upon the proposal for raising of funds. 2. If thought fit, to authorize the Managing Director of the Company. 3. Other business matters. |
| 2026-04-27 | Audited Results | |
| 2026-03-24 | Bonus issue & Others | Inter-alia, to consider 1. Increase in Authorized Share Capital subject to approval of members of the Company. 2. Other business matters. |
| 2025-11-10 | Half Yearly Results |
About Aptus Pharma
Aptus Pharma is engaged in the business of marketing, and distribution of finished pharmaceutical formulations. View More- NSE Symbol
- APPL
- BSE Symbol
- 544529
- ISIN
- INE15XJ01010
Similar Stocks to Aptus Pharma
Popular Stocks
Aptus Pharma FAQs
Aptus Pharma share price is ₹268 As on 12 August, 2026 | 01:00
The Market Cap of Aptus Pharma is ₹461 Cr As on 12 August, 2026 | 01:00
The P/E ratio of Aptus Pharma is 99.8 As on 12 August, 2026 | 01:00
The PB ratio of Aptus Pharma is 19.7 As on 12 August, 2026 | 01:00
The 52 week High & Low of Aptus Pharma is ₹310.2/₹32.3 respectively As on 12 August, 2026 | 01:00
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.